Wednesday 4 January 2017

PNG - 27.2 kb

On behalf of patients living with undiagnosed and rare diseases alliances across Europe, North America, Australia and Japan.
- 1. Undiagnosed RareDisease Patients should be recognised as a distinct population with specific unmet needs by national authorities to enable development of personalised health and social care. Although some undiagnosed diseases are common, the vast majority are rare. Hence, in this paper we refer to undiagnosed patients as “undiagnosed rare disease patients”.
- 2. National sustainable programmes dedicated specifically for undiagnosed diseases should be developed and supported by appropriate authorities in each country to enable rapid and equitable access to diagnosis and social support.
- 3. Knowledge and Information sharing should be structured and coordinated at national and international levels to optimise use of existing resourcesand facilitate access for all undiagnosed rare disease patients.
- 4. Patients should be equally involved with other stakeholders in the governance of undiagnosed diseases programmes and international networks to adequately address the priorities of undiagnosed rare disease patients and contribute to improved healthcare.
- 5. Ethical and responsible international data sharing should be promoted through existing initiatives to support diagnosis, increase clinical collaboration, facilitate research, and accelerate treatment of undiagnosed and rare conditions.
You can find more detailed information on the following link.

Follow us